🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label study of Serplulimab plus chemotherapy (Ca...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-11-18
Trial ID
NCT05468489
Lung cancer remains a leading cause of cancer-related deaths worldwide, wit...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06554535
Treatments Being Tested
Small cell lung cancer (SCLC) is one of the most aggressive lung cancer sub...
Status
Unknown
Location
Multiple Locations
Start Date
2023-06-01
Trial ID
NCT05873790
Treatments Being Tested
Small-cell lung cancer (SCLC) has a high degree of malignancy and extremely...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-31
Trial ID
NCT07141771
This is a Phase II, single arm, multicenter study designed to evaluate the ...
Status
Active Not Recruiting
Location
Chongqing University cancer hospital
Start Date
2023-03-07
Trial ID
NCT05765825
Treatments Being Tested
This study is a multi-center, Single-arm Phase II study to evaluate the cli...
Status
Unknown
Location
Jiamusi Cancer Hospital
Start Date
2022-09-23
Trial ID
NCT05443646
Treatments Being Tested
This is an open-label umbrella study conducted in first treatment ES-SCLC p...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 300060
Start Date
2025-11
Trial ID
NCT07172412
This study is a randomized, double-blind, multicenter, phase III clinical s...
Status
Active Not Recruiting
Location
OPN-Glendale
Start Date
2022-05-17
Trial ID
NCT05353257
This investigator-initiated, open-label, prospective Phase II clinical tria...
Status
Recruiting
Location
Guangdong Provincial People's Hospital
Start Date
2024-05-22
Trial ID
NCT06911606
Treatments Being Tested
To evaluates the effectiveness and safety of Surufatinib combined with Serp...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2023-06-01
Trial ID
NCT05882630
Treatments Being Tested